Zimmer Biomet Net Worth
Zimmer Biomet Net Worth Breakdown | ZBH |
Zimmer Biomet Net Worth Analysis
Zimmer Biomet's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Zimmer Biomet's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Zimmer Biomet's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Zimmer Biomet's net worth analysis. One common approach is to calculate Zimmer Biomet's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Zimmer Biomet's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Zimmer Biomet's net worth. This approach calculates the present value of Zimmer Biomet's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Zimmer Biomet's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Zimmer Biomet's net worth. This involves comparing Zimmer Biomet's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Zimmer Biomet's net worth relative to its peers.
To determine if Zimmer Biomet is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zimmer Biomet's net worth research are outlined below:
| Zimmer Biomet generated a negative expected return over the last 90 days | |
| Zimmer Biomet has a strong financial position based on the latest SEC filings | |
| Over 95.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Weekly Recap 14 Health Press Releases You Need to See |
Zimmer Biomet Quarterly Good Will |
|
Zimmer Biomet uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zimmer Biomet Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zimmer Biomet's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Zimmer Biomet's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zimmer Biomet is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zimmer Biomet Holdings backward and forwards among themselves. Zimmer Biomet's institutional investor refers to the entity that pools money to purchase Zimmer Biomet's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Van Eck Associates Corporation | 2025-03-31 | 3.7 M | Northern Trust Corp | 2025-03-31 | 2.3 M | Camber Capital Management Llc | 2025-03-31 | 2.2 M | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 2.1 M | Jpmorgan Chase & Co | 2025-03-31 | 2.1 M | Dimensional Fund Advisors, Inc. | 2025-03-31 | 2.1 M | Norges Bank | 2024-12-31 | 2 M | Citadel Advisors Llc | 2025-03-31 | 2 M | Allspring Global Investments Holdings, Llc | 2025-03-31 | 1.8 M | Vanguard Group Inc | 2025-03-31 | 23.1 M | Dodge & Cox | 2025-03-31 | 19.6 M |
Follow Zimmer Biomet's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 18.44 B.Market Cap |
|
Project Zimmer Biomet's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.12 | 0.17 | |
| Return On Capital Employed | 0.07 | 0.06 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.07 | 0.07 |
When accessing Zimmer Biomet's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Zimmer Biomet's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zimmer Biomet's profitability and make more informed investment decisions.
Evaluate Zimmer Biomet's management efficiency
Zimmer Biomet Holdings has Return on Asset of 0.0442 % which means that on every $100 spent on assets, it made $0.0442 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0732 %, implying that it generated $0.0732 on every 100 dollars invested. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities. The Zimmer Biomet's current Return On Tangible Assets is estimated to increase to 0.17, while Return On Capital Employed is projected to decrease to 0.06. As of now, Zimmer Biomet's Asset Turnover is decreasing as compared to previous years.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 61.43 | 64.50 | |
| Tangible Book Value Per Share | (5.28) | (5.55) | |
| Enterprise Value Over EBITDA | 12.05 | 17.34 | |
| Price Book Value Ratio | 1.72 | 1.63 | |
| Enterprise Value Multiple | 12.05 | 17.34 | |
| Price Fair Value | 1.72 | 1.63 | |
| Enterprise Value | 14.4 B | 12.8 B |
Zimmer Biomet's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 3.1473 | Revenue | Quarterly Revenue Growth 0.011 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zimmer Biomet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zimmer Biomet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zimmer Biomet insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zimmer Biomet Corporate Filings
| 15th of July 2025 Other Reports | ViewVerify | |
8K | 14th of July 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 7th of July 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 3rd of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Zimmer Biomet Earnings per Share Projection vs Actual
Zimmer Biomet Corporate Directors
| Arthur Higgins | Independent Director | Profile | |
| Michael Michelson | Independent Director | Profile | |
| Christopher Begley | Lead Independent Director | Profile | |
| Betsy Bernard | Independent Director | Profile |
Already Invested in Zimmer Biomet Holdings?
The danger of trading Zimmer Biomet Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zimmer Biomet is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zimmer Biomet. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zimmer Biomet Holdings is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.083 | Dividend Share 0.96 | Earnings Share 4.5 | Revenue Per Share | Quarterly Revenue Growth 0.011 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.